Pharma: Other News To Note
Monday, December 17, 2012
Bristol-Myers Squibb Co., of New York, joined the Multiple Myeloma Research Foundation pre-competitive consortium to discover and accelerate new approaches to treating multiple myeloma through the organization's Personalized Medicine Initiative.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.